In our comparison of the expression levels of target genes in fusion-positive with fusion-negative samples in each cancer type, we found four TFFGs (PML-RARA, RUNX1-RUNX1T1, TMPRSS2-ERG, and SFPQ-TFE3) that had 50 DETGs. This evidence concerns the gene TFE3 and cancer.